Article ID Journal Published Year Pages File Type
3252713 Annales d'Endocrinologie 2010 6 Pages PDF
Abstract

1. Estrogen plus progestin contraceptives (EPP) are the first-line treatment of moderate hirsutism and acne in women of child bearing age (grade C).2. CPA, 50 mg/day, 20 days out of 28, associated with estrogen is the first-line treatment of “moderate to severe hirsutism” in women of childbearing age (grade C).3. Spironolactone, given as a contraceptive, can be proposed as a second-line treatment in case of side effects or counter-indications to CPA in moderate to severe hirsutism (grade C) in women of childbearing age. No market authorization in this indication.4. Flutamide or Finasteride are “only” to be used under the guise of contraception as a “thirdline therapy” in cases of severe hirsutism, the presence of side effects or counter-indications to EPP, CPA 50 mg/day or spironolactone (grade C). No market authorization in this indication5. There is no indication for GnRH analogs as an anti-androgen treatment in women of childbearing age given the current therapeutic alternatives (grade C)6. Only long-term hair removal treatments can be proposed (grade C): electrolysis or laser hair removal.

Related Topics
Health Sciences Medicine and Dentistry Endocrinology, Diabetes and Metabolism
Authors
, , , , ,